0001104659-18-017586.txt : 20180314
0001104659-18-017586.hdr.sgml : 20180314
20180314213044
ACCESSION NUMBER: 0001104659-18-017586
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180312
FILED AS OF DATE: 20180314
DATE AS OF CHANGE: 20180314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hoberman Kenneth
CENTRAL INDEX KEY: 0001573722
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35619
FILM NUMBER: 18690900
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVENUE, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STEMLINE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001264587
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450522567
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
STREET 2: ELEVENTH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 646-502-2311
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
a4.xml
4
X0306
4
2018-03-12
0
0001264587
STEMLINE THERAPEUTICS INC
STML
0001573722
Hoberman Kenneth
C/O STEMLINE THERAPEUTICS, INC.
750 LEXINGTON AVENUE, ELEVENTH FLOOR
NEW YORK
NY
10022
0
1
0
0
Chief Operating Officer
Common Stock
2018-03-12
4
S
0
13942
17.18
D
425639
D
Common Stock
2018-03-12
4
S
0
3299
18.24
D
422340
D
Common Stock
2018-03-13
4
S
0
12746
16.82
D
409594
D
In connection with the vesting of 32,868 shares on March 9, 2018, a total of 13,942 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
Reflects the weighted average sale price. The range of prices for such transaction is $16.70 to $17.70. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Of the 425,639 shares, 293,990 shares are restricted stock.
In connection with the vesting of 32,868 shares on March 9, 2018, a total of 3,299 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
Reflects the weighted average sale price. The range of prices for such transaction is $17.73 to $18.70. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Of the 422,340 shares, 293,990 shares are restricted stock.
In connection with the vesting of 25,000 shares on March 12, 2018, a total of 12,746 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
Reflects the weighted average sale price. The range of prices for such transaction is $16.55 to $17.18. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Of the 409,594 shares, 268,990 shares are restricted stock.
/s/ Kenneth Hoberman
2018-03-14